Favières, France

Isabelle Callebaut


 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Favières, FR (2007)
  • Favieres, FR (2019)

Company Filing History:


Years Active: 2007-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle Callebaut

Introduction

Isabelle Callebaut is a prominent inventor based in Favières, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cystic fibrosis and the development of synthetic leptin antagonists. With a total of 2 patents to her name, her work has the potential to impact many lives.

Latest Patents

Callebaut's latest patents include groundbreaking inventions. One of her notable patents involves compounds for treating cystic fibrosis. This invention relates to compounds of Formula (I) or pharmaceutically acceptable enantiomers, salts, solvates, or prodrugs thereof. The invention further explores the use of these compounds for the treatment of cystic fibrosis and outlines a process for manufacturing them. Another significant patent focuses on synthetic leptin antagonists. This invention describes synthetic leptin antagonists in which at least two amino acid residues of the sequence LDFI/S of the hydrophobic binding site are substituted with different amino acid residues, making the site less hydrophobic. This patent also includes fragments of the leptin antagonists.

Career Highlights

Throughout her career, Isabelle Callebaut has worked with esteemed organizations. She has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Universités Paris 6 et Paris 7. Her work in these institutions has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Callebaut has collaborated with notable individuals in her field, including Arieh Gertler and Jean Djiane. These collaborations have enriched her research and expanded the impact of her inventions.

Conclusion

Isabelle Callebaut's innovative work in pharmaceuticals showcases her dedication to improving health outcomes through her inventions. Her contributions, particularly in the treatment of cystic fibrosis and the development of synthetic leptin antagonists, highlight her role as a leading inventor in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…